|
2025
|
G/S
|
Pharmaceutical preparations for the treatment of auditory, hematological, gastrointestinal, neuro... |
|
2024
|
G/S
|
Medical apparatuses |
|
|
G/S
|
Medical apparatus and devices. |
|
|
G/S
|
Pharmaceutical preparations for the treatment of hematological, gastrointestinal, neuromuscular, ... |
|
|
Invention
|
Vegf antagonist formulations suitable for intravitreal administration.
Ophthalmic formulations o... |
|
|
Invention
|
Anti-vegf protein compositions and methods for producing the same.
The present disclosure pertai... |
|
|
Invention
|
Unbiased and high-throughput identification and quantification of host cell protein impurities by... |
|
|
Invention
|
Methods of effecting a hemodynamic change by administering an anti-npr1 antibody.
The present di... |
|
|
G/S
|
Pharmaceutical preparations for the treatment of cardiovascular, metabolic, hematological, immuno... |
|
|
Invention
|
Tandem mass tag multiplexed quantitation of post-translational modifications of proteins.
Disclo... |
|
|
G/S
|
Platform as a service (PAAS) featuring computer software platforms for genetic research and scien... |
|
|
G/S
|
Business administration services, namely, business administration of a program to provide access ... |
|
|
G/S
|
Platform as a service (PAAS) featuring computer software platforms for genetic research and gene ... |
|
|
Invention
|
Use of bispecific antigen-binding molecules that bind muc16 and cd3 in combination with 4-1bb co-... |
|
|
Invention
|
Treatment of hyperglycemia with solute carrier family 39 member 5 (slc39a5) inhibitors.
The pres... |
|
|
G/S
|
Capital investment; investment management; equity capital investment; providing venture capital, ... |
|
|
G/S
|
Capital investment; investment management; equity capital
investment; providing venture capital,... |
|
|
Invention
|
Cancer therapies targeting vista as monotherapy or in combination with anti-pd1 antibody to treat... |
|
|
Invention
|
Methods of treating metastatic castration-resistant prostate cancer with bispecific anti-psma x a... |
|
|
Invention
|
Methods of treating clear cell renal cell carcinoma with bispecific anti-psma x anti-cd28 antibod... |
|
|
Invention
|
Methods for reducing the likelihood of and treating graft-versus-host disease. The present disclo... |
|
|
Invention
|
Automation-enabled methods for characterizing non-consensus n- and o-glycans in proteins. The pre... |
|
|
Invention
|
Anti-tfr:gaa and anti-cd63:gaa insertion for treatment of pompe disease. ALBALB locus and/or expr... |
|
|
Invention
|
Anti-tfr:gaa and anti-cd63:gaa insertion for treatment of pompe disease.
Nucleic acid constructs... |
|
|
Invention
|
Anti-tfr: acid sphingomyelinase for treatment of acid sphingomyelinase deficiency. Multidomain th... |
|
|
Invention
|
Use of bgh-sv40l tandem polya to enhance transgene expression during unidirectional gene insertio... |
|
|
Invention
|
Methodology to characterize empty-full ratio in crude aav samples.
The present invention provide... |
|
|
Invention
|
Methodology to characterize empty-full ratio in crude aav samples. The present invention provides... |
|
|
Invention
|
Anti-factor xii/xiia antibodies and uses thereof. The present invention provides monoclonal antib... |
|
|
Invention
|
Systems and methods for motor assessment.
Systems and methods for motor assessment including rec... |
|
|
Invention
|
Systems and methods for motor assessment. Embodiments disclosed herein are directed to systems an... |
|
|
G/S
|
Medical apparatuses |
|
|
Invention
|
Methods of treating skin cancer with carboxypeptidase vitellogenic like (cpvl) inhibitors.
The p... |
|
|
Invention
|
Methods and systems for detection of abnormal karyotypes.
Methods and systems for detecting abno... |
|
|
Invention
|
Bispecific pd-l1xcd28 antibodies and methods of use thereof.
The present disclosure provides bis... |
|
|
Invention
|
Bispecific pd-l1x4-1bb antibodies and methods of use thereof.
The present disclosure provides bi... |
|
|
Invention
|
Bispecific pd-l1xcd28 antibodies and methods of use thereof. The present disclosure provides bisp... |
|
|
Invention
|
Bispecific pd-l1x4-1bb antibodies and methods of use thereof. The present disclosure provides bis... |
|
|
Invention
|
Stabilized formulations containing anti-bcma x anti-cd3 bispecific antibodies.
The present inven... |
|
|
Invention
|
Stabilized formulations containing anti-bcma x anti-cd3 bispecific antibodies. The present invent... |
|
|
G/S
|
Pharmaceutical preparations and substances for the treatment of diseases, namely, genetic disease... |
|
|
Invention
|
Anti-il36r antibodies.
The present invention provides antibodies and antigen-binding fragments (... |
|
|
Invention
|
Methods of analyzing and characterizing messenger ribonucleic acid (mrna) and polyadenylation on ... |
|
|
Invention
|
Methods and compositions for increasing homology-directed repair. Provided herein are combination... |
|
|
G/S
|
Medical assistance services in the field of treatment of cardiovascular diseases; Providing medic... |
|
|
Invention
|
Cd79a chimeric antigen receptors.
The invention provides improved compositions for adoptive cell... |
|
|
Invention
|
Extended, high dose vegf antagonist regimens for treatment of angiogenic eye disorders.
The pres... |
|
|
Invention
|
Off-target prediction method for antigen-recognition molecules binding to mhc-peptide targets.
C... |
|
|
Invention
|
Methods for purifying filled adeno-associated virus capsids. The inventions provide methods of pu... |
|
|
Invention
|
Circularized antibody molecules.
The present disclosure provides circularized antibody molecules... |
|
|
Invention
|
Adoptive cellular therapy.
The invention provides improved compositions and methods for the trea... |
|
|
Invention
|
Low affinity fcyr deficient mice.
Genetically modified non-human animals and methods and composi... |
|
|
Invention
|
Anti-il-33 antibodies and uses thereof.
The present invention provides antibodies that bind to i... |
|
|
Invention
|
Anti-pdgf-b antibodies and pharmaceutical composition thereof.
The present disclosure provides a... |
|
|
G/S
|
Medical and pharmaceutical consultation; Medical assistance services; Medical information |
|
|
G/S
|
Anti-inflammatory preparations; anti-viral agents; pharmaceutical anti-allergic preparations and ... |
|
|
Invention
|
Novel il2 agonists and methods of use thereof.
The present disclosure relates to IL2 agonists wi... |
|
|
Invention
|
Retainer adapter assembly |
|
|
G/S
|
Capital investment; Investment management; Equity capital investment; Providing venture capital, ... |
|
2023
|
Invention
|
Anti-human cacng1 antibody-drug conjugates and uses thereof. Provided herein are antigen-binding ... |
|
|
Invention
|
Botulinum neurotoxin-specific capture agents, compositions, and methods of using and making.
The... |
|
|
Invention
|
Crispr-mediated transgene insertion in neonatal cells.
Compositions and methods for inserting a ... |
|
2022
|
Invention
|
Mutant myocilin disease model and uses thereof.
Non-human animal genomes, non-human animal cells... |
|
|
Invention
|
Methods and compositions for reducing centralized pain.
Methods and compositions for treating ce... |
|
|
Invention
|
Non-human animals comprising a modified cacng1 locus.
Non-human animal cells and non-human anima... |
|
|
Invention
|
Protein-antiviral compound conjugates.
Provided herein are compounds, compositions, and methods ... |
